Dawn C. Buse, PhD
Advertisement
Articles by Dawn C. Buse, PhD
Reducing the frequency of migraine is only 1 step in the process of optimizing management and addressing the disease's impact on patients’ lives.
Advertisement
Latest Updated Articles
Patient Selection of Novel Therapies for Migraine TreatmentPublished: October 28th 2020 | Updated:
Unmet Needs in the Management of MigrainePublished: October 28th 2020 | Updated:
Behavioral and Lifestyle Strategies for Migraine ManagementPublished: October 28th 2020 | Updated:
Acute Treatment of Migraine: Traditional TherapiesPublished: October 28th 2020 | Updated:
Role of Neuromodulation for Acute Treatment of MigrainePublished: October 28th 2020 | Updated:
Evolution of Acute Treatment of MigrainePublished: October 28th 2020 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Action Update, November 2025: Approvals, Clearance, and Boxed Warning
2
FDA Accepts NDA for Low-Sodium Oxybate TRN-257 in Narcolepsy and Idiopathic Hypersomnia
3
Cell Therapy Deramiocel Meets Primary End Point in Phase 3 DMD Cardiomyopathy Trial
4
Understanding the Mechanism and Rationale of Azetukalner to Treat Focal Epilepsy: Christopher Kenney, MD, FAAN
5
